Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00664859 · ClinicalTrials.gov registry record · Phase 2
12-Month, Open-Label, Extension Study of LCP-AtorFen in Dyslipidemia
A Phase 2 study, sponsored by Veloxis Pharmaceuticals.
- Completed
- Registry status
- Phase 2
- Development phase
- 140
- Enrollment target
NCT00664859 is a Phase 2 study that has completed, run by Veloxis Pharmaceuticals. The registered enrollment target is 140 participants.
The verdict
NCT00664859, a Phase 2 study, has completed, sponsored by Veloxis Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 140 participants
- Enrollment target
Study Summary
The current study is designed to test the long-term (12-month) safety and efficacy of LCP-AtorFen, a combination of atorvastatin and fenofibrate, in patients with dyslipidemia
Interventions
- DRUG LCP-AtorFen
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 140 participants |
| Start Date | 2007-10 |
| Est. Completion | 2009-02 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00664859
The ClinicalTrials.gov registry entry for NCT00664859 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 140 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Veloxis Pharmaceuticals, which has 15 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which LCP-AtorFen is the first listed.
NCT00664859 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00664859 about?
NCT00664859 is a clinical study titled "12-Month, Open-Label, Extension Study of LCP-AtorFen in Dyslipidemia". The current study is designed to test the long-term (12-month) safety and efficacy of LCP-AtorFen, a combination of atorvastatin and fenofibrate, in patients with dyslipidemia
What is the current status of trial NCT00664859?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 140 participants. The study started on 2007-10. Estimated completion is 2009-02.
What interventions are being tested in trial NCT00664859?
The interventions under investigation include: LCP-AtorFen (DRUG).
Who is sponsoring clinical trial NCT00664859?
This trial is sponsored by Veloxis Pharmaceuticals, which has 15 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.